Literature DB >> 3802497

Determination of neopterin in serum and urine.

E R Werner, A Bichler, G Daxenbichler, D Fuchs, L C Fuith, A Hausen, H Hetzel, G Reibnegger, H Wachter.   

Abstract

Concentrations of neopterin, a product of activated macrophages, in serum from 662 apparently healthy individuals (ages 1 to 97 years, median 22 years) were measured by radioimmunoassay and the results statistically analyzed. Consistent with prior investigations on the urinary excretion of neopterin, we found no significant sex dependence, but values for subjects younger than 18 or older than 75 years were significantly higher. Renal clearance of neopterin in nine healthy individuals was 218 (SD 44) mL/min, which suggests that the kidneys have an active role in neopterin excretion. Results for neopterin concentrations measured in serum by RIA and "high-performance" liquid chromatography (HPLC) are consistent, but for urinary neopterin the concordance between methods was weak. Therefore, the RIA should be used only for measuring neopterin in serum. In comparison of the clinical utility of serum neopterin and urinary neopterin/creatinine concentrations, in patients with gynecological tumors, the latter values (measured by HPLC) discriminated slightly better between patients with favorable and unfavorable prognoses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3802497

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  30 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Postmortem neopterin concentrations: comparison of diagnoses with and without cellular immunological background.

Authors:  E Ambach; W Tributsch; W Rabl; D Fuchs; G Reibnegger; R Henn; H Wachter
Journal:  Int J Legal Med       Date:  1991       Impact factor: 2.686

3.  Evaluation of neopterin as a marker for restenosis following percutaneous transluminal coronary angioplasty.

Authors:  B Eber; M Schumacher; F Tatzber; P Kaufmann; O Luha; H Esterbauer; R Gasser; W Klein
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

4.  Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Authors:  Michael J Peluso; Francesca Ferretti; Julia Peterson; Evelyn Lee; Dietmar Fuchs; Antonio Boschini; Magnus Gisslén; Nancy Angoff; Richard W Price; Paola Cinque; Serena Spudich
Journal:  AIDS       Date:  2012-09-10       Impact factor: 4.177

5.  Gamma interferon is dispensable for neopterin production in vivo.

Authors:  R Sghiri; J Feinberg; F Thabet; K Dellagi; J Boukadida; A Ben Abdelaziz; J L Casanova; M R Barbouche
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

6.  Increased urinary zinc excretion in cancer patients is linked to immune activation and renal tubular cell dysfunction.

Authors:  B Melichar; F Malír; P Jandík; E Malírová; J Vávrová; J Mergancová; Z Voboril
Journal:  Biometals       Date:  1995-07       Impact factor: 2.949

7.  Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.

Authors:  K L Lim; A C Jones; N S Brown; R J Powell
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

8.  Neopterin: Biomarker of cell-mediated immunity and potent usage as biomarker in silicosis and other occupational diseases.

Authors:  Shubhangi K Pingle; Rajani G Tumane; Aruna A Jawade
Journal:  Indian J Occup Environ Med       Date:  2008-12

9.  Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia.

Authors:  Frauke M von Versen-Hoeynck; Carl A Hubel; Marcia J Gallaher; Hilary S Gammill; Robert W Powers
Journal:  Am J Hypertens       Date:  2009-03-12       Impact factor: 2.689

10.  Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.

Authors:  Aylin Yilmaz; Richard W Price; Serena Spudich; Dietmar Fuchs; Lars Hagberg; Magnus Gisslén
Journal:  J Acquir Immune Defic Syndr       Date:  2008-02-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.